A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer

NCT00480584 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Pancreatic Carcinoma

Interventions

DRUG: gemcitabine
DRUG: capecitabine
DRUG: erlotinib

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]